Marilyn Albert|Steven T. DeKosky|Dennis W. Dickson|Bruno Dubois|Howard Feldman|Nick C. Fox|Anthony Gamst|David M. Holtzman|William J. Jagust|Ronald C. Petersen|Peter J. Snyder|María C. Carrillo|Bill Thies|Creighton H. Phelps
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging?Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Johns Hopkins Medicine|Johns Hopkins University|University of Virginia|Mayo Clinic in Florida|Winneshiek Medical Center|Institut du Cerveau|Inserm|Bristol-Myers Squibb (United States)|University College London|University of California, San Diego|Washington University in St. Louis|Prevent Alzheimer’s Disease 2020|University of California, Berkeley|Mayo Clinic in Arizona|Brown University|Providence College|Rhode Island Hospital|Alzheimer's Association|Alzheimer's Association|National Institute on Aging
national institute aging alzheimers association charged workgroup task developing criteria symptomatic predementia phase alzheimers disease ad referred article mild cognitive impairment due ad workgroup developed following two sets criteria 1 core clinical criteria could used healthcare providers without access advanced imaging techniques cerebrospinal fluid analysis 2 research criteria could used clinical research settings including clinical trials second set criteria incorporate use biomarkers based imaging cerebrospinal fluid measures final set criteria mild cognitive impairment due ad four levels certainty depending presence nature biomarker findings considerable work needed validate criteria use biomarkers standardize biomarker analysis use community settings